CellaVision AB Stock: price and insider trades · Sweden

CellaVision AB, founded in 1994, is a Health Care company based in Lund, Sweden. Its directors and officers file their transactions with Finansinspektionen. The last twelve months, up to 31 October 2026, brought 15 filings signed by 7 insiders.

Every open-market trade in the period is a purchase: 13 purchases worth €7.2M, from 6 insiders, and not a single sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. christer Fåhraeus filed the largest purchase, €2.7M, on 28 April 2026. On the buying side, the filings list 6 board members among the declarants.

Across the 1,035 companies tracked on its exchange, the median is 9 filings; at 15 filings, this issuer sits above that mark. Looking back to 2016, when coverage begins, insiders filed 39 purchases and 14 sales.

In the case of 8 purchases, another manager of the company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The last purchase on record was published on 12 June 2026, which is 148 days ago. Typically, a trade is published a median of 1 day after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade.

In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.